Clinical Trials. inc.

Little Rock, Arkansas 72205-6421

4 studies enrolling now · 48 studies all time

What they study most

Acute Repetitive Seizures, Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Alzheimer's Disease, B Vitamin Deficiency, Breakthrough Seizures, Constipation, Diabetic Neuropathy, Painful, Diabetic Peripheral Neuropathic Pain, Diabetic Peripheral Neuropathy, Drug Resistant Partial Onset Seizure, Epilepsies, Partial

Studies at this site

• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) — Recruiting now
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Recruiting now
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy — Running, not enrolling
• Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Running, not enrolling
• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures — Completed
• Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
• Phase 3 Gene Therapy for Painful Diabetic Neuropathy — Completed
• Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy — Completed
• A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures — Completed
• A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease — Running, not enrolling
• Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Running, not enrolling
• Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET) — Completed
• Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease — Completed
• Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension — Completed
• A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment — Completed
• Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures — Completed
• Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects — Completed
• AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext — Completed
• Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures — Completed
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed
• Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo — Completed
• A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy — Stopped early
• Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern — Completed
• Once-A-Day Pregabalin For Partial Seizures — Completed
• Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures — Completed
• A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes — Completed
• Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial — Completed
• A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) — Stopped early
• Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures — Completed
• Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures — Stopped early
• An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease — Completed
• A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease — Completed
• Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy — Completed
• Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. — Completed
• Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients — Stopped early
• Study of the Safety, Tolerability and Efficacy of V3381 in Patients With Diabetic Peripheral Neuropathic Pain — Completed
• The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN) — Status unconfirmed
• Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients — Stopped early
• A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study for the Pain of Diabetic Peripheral Neuropathy — Completed
• A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis — Completed
• Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures — Completed
• A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease — Stopped early
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations — Completed